MIT Discovery Advances Cancer Diagnostics

A new diagnostic approach technology can predict how patients will respond to hundreds of different drugs or drug combinations before the patients even take the drugs.

This advance has lead to the formation of Travera a Cambridge MA based startup to commercialize this advance. The firm’s new measurement tool, the Suspended Microchannel Resonator (SMR), reveals cancer cells’ responses to effective drugs faster than ever before. Travera tests drugs, to maximize drug quality and effectiveness … Read More